Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
|||||||
GSM4681460 |
shLuc vs. shBLCAP cells
|
RNA | 2 | Ying-Tzu Huang | Aug 28, 2022 | ||||
GSM6500151 |
NT ECs with histamine treatment bio rep 1
|
SRA | 1 | Jiayi Chen | Aug 28, 2022 | ||||
GSM6500152 |
NT ECs with histamine treatment bio rep 2
|
SRA | 1 | Jiayi Chen | Aug 28, 2022 | ||||
GSM6500153 |
NT ECs with histamine treatment bio rep 3
|
SRA | 1 | Jiayi Chen | Aug 28, 2022 | ||||
GSM6500154 |
HRH1 KD ECs with histamine treatment bio rep 1
|
SRA | 1 | Jiayi Chen | Aug 28, 2022 | ||||
GSM6500155 |
HRH1 KD ECs with histamine treatment bio rep 2
|
SRA | 1 | Jiayi Chen | Aug 28, 2022 | ||||
GSM6500156 |
HRH1 KD ECs with histamine treatment bio rep 3
|
SRA | 1 | Jiayi Chen | Aug 28, 2022 | ||||
GSM6508536 |
H1299 K3Q [batch 1, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508537 |
H1299 Ctr [batch 1, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508538 |
H1299 K3R [batch 1, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508539 |
H1299 WT [batch 1, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508540 |
H1299 K3Q [batch 2, bio rep 2]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508541 |
A549 WT [batch 2, bio rep 2]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508542 |
H1299 Ctr [batch 2, bio rep 2]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508543 |
A549 K3Q [batch 2, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508544 |
H1299 Ctr [batch 2, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508545 |
A549 K3R [batch 2, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508546 |
A549 Ctr [batch 2, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508547 |
H1299 WT [batch 2, bio rep 1]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 | ||||
GSM6508548 |
A549 K3Q [batch 2, bio rep 2]
|
SRA | 1 | Zezhuo Su | Aug 28, 2022 |